Skin fibroblast cells - version 1
Research type
Research Study
Full title
Ageing in skin fibroblast cells
IRAS ID
187622
Contact name
David Gunn
Contact email
Sponsor organisation
Unilever Research
Duration of Study in the UK
9 years, 10 months, 31 days
Research summary
Skin ageing is the most visible and discernible manifestation of the ageing process. As an outcome of advanced skin ageing, skin cancer is one the most common cancers in the UK, with rates of malignant melanoma in Great Britain rising faster than any of the current ten most common cancers (source:- Cancer Research UK). Unilever is a large foods, home and personal care company, selling many forms of skin creams and products throughout the world. To innovate new products that can reduce the rate of, or even reverse, skin ageing, human skin cells derived from biopsy studies are an invaluable resource. Such cells offer a long-term resource which enable in-depth molecular biology research into skin ageing and prevents the need for regularly sourcing new skin biopsies. Currently, there are a number of skin fibroblast cell strains at Unilever Colworth in the UK which were derived from skin biopsies studies carried out in 1998-2001. This protocol outlines the continued use of these fibroblast cells to further the advancement of new skin anti-ageing treatments.
REC name
West Midlands - Black Country Research Ethics Committee
REC reference
16/WM/0041
Date of REC Opinion
8 Feb 2016
REC opinion
Favourable Opinion